← Emergent Ventures/Schmidt (new grantor for individual researchers) AMBER General
Programme Research
Emergent Ventures/Schmidt (new grantor for individual researchers) · Emergent Ventures/Schmidt
Programme Site
MEDIUM confidence Researched 2026-08-04 20:43 · profile: researcher
Emergent Ventures is a fast, rolling grant program by Tyler Cowen and the Mercatus Center that funds high-impact, unconventional individuals and projects, with a special tranche co-funded by Eric Schmidt to identify and foster AI researchers. It exists to support risk-taking, contrarian thinkers who have promising ideas but lack traditional institutional backing, aiming to generate outsized social and economic returns.
- No formal eligibility restrictions; open to individuals worldwide, including non-traditional researchers and entrepreneurs. - Emphasis on high expected value, intellectual ambition, and potential for transformative impact. - Preference for contrarian, independent, and self-directed applicants who pursue novel approaches. - For the AI tranche, focus on AI researchers, but not limited to safety; capability research also considered. - Rolling applications, quick decisions, and minimal bureaucracy; no lengthy forms or strict deadlines. - Grants are typically small ($5K-$100K) and can be used flexibly (e.g., research, travel, equipment, living expenses). - Reviewers look for evidence of initiative, past output, and a clear plan for how the grant will accelerate progress.
Past winners include a diverse mix of young researchers, entrepreneurs, and writers, often with unconventional backgrounds. Examples include AI safety researchers, biotech innovators, and policy entrepreneurs. The program explicitly seeks 'underrated' and 'high-variance' individuals, so winners often have a track record of independent projects, preprints, or startups rather than traditional academic credentials.
The platonic ideal applicant is a brilliant, self-starting individual with a bold, high-impact idea that is too risky or unconventional for traditional funding. They are likely early-career, have demonstrated initiative through independent research or ventures, and can articulate a clear, ambitious plan that the grant would unlock. They are contrarian, intellectually curious, and not afraid to challenge orthodoxy.
For Eniola, the strongest angle is to lead with the CCT model as a high-risk, high-reward, contrarian approach to addiction treatment, emphasizing its interdisciplinary nature (pharmacology, computational modeling, Bayesian methods) and its potential to disrupt conventional addiction research. Frame it as an independent, pre-PhD researcher who has already produced multiple preprints and validated hypotheses, and who needs flexible funding to pursue the next steps (e.g., experimental validation, collaboration with Berridge/Daw) that traditional grants would not support. This aligns with Emergent Ventures' preference for bold, unconventional, and self-directed researchers.
None apparent. However, the applicant's broad portfolio might dilute focus; the application should clearly prioritize one flagship project (CCT) to avoid appearing scattered. Also, as an independent researcher without a PhD, some reviewers might question credibility, but the strong publication record and endorsements mitigate this.
2026-08-04 20:08 · medium confidence
2026-07-31 00:48 · medium confidence